Rinvoq 00074-1043
Generic: Upadacitinib
Product NDC
00074-1043- Manufacturer
- Abbvie Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 16, 2019
- Listing Expires
- December 31, 2027
- Application
- NDA211675
Need to source Rinvoq? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Upadacitinib | 45 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Packaging Options(2)
14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14)
28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28)